Femasys (FEMY) - EV/EBITDA Multiple
Femasys Inc. (FEMY) is developing minimally invasive solutions for the reproductive health sector, establishing a benchmark standard for diagnostics and contraception. The company attracts leading biomedical experts through high bonuses and strict compliance with FDA regulations. A stable supply of polymers and assembly within the US guarantee uninterrupted product output. This chart on GURU.Markets shows that the EV/EBITDA ratio is 0.00.
Analytical breakdowns for femasys.com (FEMY)
- stock price and consensus target price:
- market capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
- business earnings and investment ratios data:
FEMY - Company Net Income|Expected Profit Femasys Inc.|FEMY - Price to Earnings Multiple|Projected Price to Earnings Femasys Inc.|FEMY - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Femasys Corporation|FEMY - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Femasys|FEMY - Earnings per one share for the last 12 months|Quarterly EPS earnings growth femasys.com|FEMY - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Femasys Inc.
Summary company analysis:Femasys Corp (FEMY)
High debt leverage and tax obligations leave the business vulnerable to market shocks, making the EV/EBITDA ratio on the valuation chart critical for determining the asset's real price relative to its operating profit. Femasys Inc. maintains profitability through efficient component logistics, allowing investors to use this indicator to assess the fairness of the market capitalization and the risk of overpaying for the company.
Competitors of Femasys Inc.
Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|UTMD: EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio KRMD (KORU Medical)|NYXH (Nyxoah S.A.) - EV/EBITDA Multiple|Company Value to EBITDA microbotmedical.com MBOT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pro-Dex (PDEX)|Enterprise Value to EBITDA Ratio Zentek Ltd ZTEK|EV/EBITDA Multiple ELUT (Elutia Corp)|EV/EBITDA Multiple Milestone Scientific Corporation MLSS|NXGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Retractable Technologies RVP|HBIO (Harvard Bioscience) - Enterprise Value to EBITDA Ratio|Company Value to EBITDA Meihua Medical Technologies Co., Ltd. (MHUA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Predictive Oncology Inc|Callan JMB Corp (CJMB) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ATRI (Atrion Corporation)|NURO (neurometrix.com) - Business Value to Operating Income Before Depreciation
